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Abstract The glucose transporter of Escherichia coli couples
translocation with phosphorylation of glucose. The IICBGlc
subunit spans the membrane eight times. Split, circularly
permuted and cyclized forms of IICBGlc are described. The split
variant was 30 times more active when the two proteins were
encoded by a dicistronic mRNA than by two genes. The stability
and activity of circularly permuted forms was improved when
they were expressed as fusion proteins with alkaline phosphatase.
Cyclized IICBGlc and IIAGlc were produced in vivo by RecA
intein-mediated trans-splicing. Purified, cyclized IIAGlc and
IICBGlc had 100% and 30% of wild-type glucose phospho-
transferase activity, respectively. Cyclized IIAGlc displayed
increased stability against temperature and GuHCl-induced
unfolding. ß 2001 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
1.1. Membrane proteins
Membrane proteins are estimated to account for 10^40% of
all proteins in bacteria. The membrane lipid bilayer, however,
occupies less than 4% of the cell volume. Therefore, the con-
centration of individual membrane proteins is low and the
space accessible for overexpression is limited. Exceptions are
a few proteins in convoluted membranes of increased surface
area and volume. Nevertheless, membrane proteins can be
overexpressed in large amounts and in a functional form.
The membrane bilayer apparently accommodates an excess
of proteins by folding up. Insertion of membrane proteins
into the lipid bilayer is not spontaneous but is catalyzed by
an ATP driven secretion machinery [1]. Folding begins with
the insertion of a signal sequence presumably the most N-
terminal membrane spanning segment [2]. The sequential in-
sertion of the more distal hydrophobic stop transfer and in-
ternal signal sequence then determines the overall topology of
the protein.
For puri¢cation, membrane proteins and lipids must be
separated by solubilization with detergents [3]. In this process,
a large proportion of the protein surface becomes buried in
the detergent micelle, and only a small surface remains acces-
sible for protein^protein contacts. The scarcity of polar sur-
faces makes crystallization of membrane proteins di⁄cult.
Ostermeier and Michel used conformation-speci¢c antibodies
against membrane proteins to increase the polar surface and
successfully cocrystallized cytochrome c oxidase with a native
conformation-speci¢c Fv fragment [4]. More recently, Carola
Hunte used the same approach to solve to 2.3 Aî the structure
of the bc1 complex ([5] and this issue [68]).
Many membrane spanning proteins have extramembranous
domains, which can be expressed as soluble recombinant pro-
teins and crystallized. These domains might provide contact
surfaces similar to the Fv fragments. However, if too £exible,
such a contact might fail to produce a rigid orientation of the
membrane domain by the soluble one.
Prompted by the spectacular successes achieved by Oster-
meier and Hunte, we wondered whether the rigid protein^
antibody interaction could be mimicked by a two-point an-
choring of a soluble to a membrane domain. As the ¢rst step
to strengthen the connection, the C-terminus of a cytoplasmic
domain was fused with the N-terminus of a membrane do-
main by circular permutation and cyclization of the polypep-
tide chain. The glucose transporter of the phosphoenolpyru-
vate: (PEP) sugar phosphotransferase system (PTS) of
Escherichia coli was utilized, because it can be overexpressed
and puri¢ed e⁄ciently, and because phosphotransferase activ-
ity can be assayed more conveniently than vectorial transport.
1.2. The bacterial PTS
Bacteria utilize di¡erent transport mechanisms for the up-
take of solutes: facilitated di¡usion, active transport driven by
ATP or ion-gradients and group translocation (Fig. 1A).
Group translocation of carbohydrates is mediated by the bac-
terial PEP: PTS [6]. The PTS catalyzes translocation with
concomitant phosphorylation of sugars and hexitols and it
also regulates the metabolism in response to the availability
of carbohydrates [7,8]. PTSs consist of two cytoplasmic pro-
teins, enzyme I (EI) and HPr, and a variable number of sugar-
speci¢c transport complexes (Enzymes IIsugar) (Fig. 1B). EI
transfers phosphoryl groups from PEP to the phosphoryl car-
rier protein HPr. HPr then transfers the phosphoryl groups to
the di¡erent transport complexes. PTSs are ubiquitous in eu-
bacteria but do not occur in archaebacteria and eukaryotes.
The amino acid sequences of EI and HPr are strongly con-
served in all bacteria. The number and structure of PTS trans-
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porters vary between species. They can be grouped by se-
quence comparison into four structurally very di¡erent fami-
lies [9]. The E. coli genome encodes 38 di¡erent PTS proteins,
33 of which are subunits belonging to 22 di¡erent transport-
ers. The Mycoplasma genitalium genome contains one gene for
EI and HPr each and only two genes for PTS transporters
(Fig. 1A). The genomes of Treponema pallidum, Chlamydia
trachomatis and Xylella fastidiosa (a plant pathogen) contain
EI- and HPr-like proteins but no PTS transporters. Mycobac-
terium tuberculosis has no PTS.
PTS transporters consist of three functional units, IIA, IIB
and IIC, which occur either as protein subunits in a complex
(e.g. IIAGlcWIICBGlc) or as domains of a single polypeptide
chain (e.g. IICBAGlcNAc) (Fig. 2). IIA and IIB sequentially
transfer phosphoryl groups from HPr to the transported sug-
ars. IIC contains the sugar binding site. EI, HPr und IIA are
phosphorylated at His, IIB domains are phosphorylated at
either Cys or His depending on the particular transporter.
The IIA und IIB domains of the di¡erent families of PTS
transporters have completely di¡erent folds (Fig. 3, reviewed
in [10]). IIAGlc of E. coli is a sandwich of two L-sheets each
consisting of six antiparallel L-strands and two very short
K-helices. IIAMtl is a ¢ve-stranded mixed L-sheet with K-heli-
ces on both faces. IIAMan of E. coli is a homodimer of open-
twisted K/L subunits. The dimer is stabilized by a swap of
L-strands between the subunits. IIALac of Lactococcus lactis
is a homotrimer of three-helix-bundle subunits. IIBGlc consists
Fig. 1. A: Common transport mechanisms for small solutes in the
inner membrane of bacteria. Facilitation (black), secondary ion-sym-
port (blue), primary ATP-dependent transport (green), group trans-
location (red). The numbers refer to the number of paralogous pro-
teins in E. coli (left) and M. genitalium (right). The genomes of
E. coli and M. genitalium contain 4300 and 470 genes of which 25%
to 40%, and 10% to 30% respectively, encode putative membrane
proteins. B: Phosphotransfer chain of the glucose PTS. Phosphoryl
groups are sequentially transferred from PEP to EI (63 kDa), HPr
(9 kDa) and hence to the carbohydrate transporter IIAGlc (18 kDa)
and IICBGlc (51 kDa). Proteins are phosphorylated at His and Cys.
The red arrows emphasize the reversibility of the phosphotransfer
reaction. The blue arrows indicate regulatory interactions but do
not imply direct protein^protein contacts between the PTS compo-
nents and the regulated targets (see Fig. 4).
Fig. 2. Modular design of the PTS. Shown are representative exam-
ples of the glucose/L-glucoside (red, orange), mannose (blue), fruc-
tose/mannitol (green) and lactose/chitobiose (cyan) families from E.
coli and P. aerugionsa. Also shown is the heterotrimeric dihydroxy-
acetone kinase (purple/blue). The functional units EI, HPr, IIA, IIB
and IIC are vertically aligned. The FruA subunit of E. coli and
IICBGlcNAc of P. aeruginosa have duplicated B domains. Solid and
open circles indicate phosphorylated His and Cys, respectively. Ar-
rows indicate phosphotransfer between HPr and the sugar-speci¢c
IIA domains, and between homologous IIA and IIB domains of dif-
ferent transporters. The recombinant multidomain protein was ob-
tained by connecting the EI, HPr, IIAGlc and IICBGlc units with the
Ala^Pro rich linkers taken from the IIABMan subunit of the man-
nose transporter [56]. The protein symbols are drawn to scale with
the pointed end marking the C-terminus. Swiss-Prot accession codes
are: E. coli IIBCABgl, P08722; IIAGlc/IICBGlc, P08837/P05053;
IICBAGlcNAc, P09323; IIABMan/IICMan/IIDMan, P08186/P08187/
P08188; Dha Kinase, P37349/P76015/P76015; FruB/FruA, P24217/
P20966; IIACel/IICCel/IICCel, P17335/P17409/P17334; P. aeruginosa
MTPGlcNAc/IICBGlcNAc Q9HXN5/Q9HXN4.
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of a four-stranded antiparallel L-sheet covered on one face by
three helices. IIBCel and IIBMan have open-twisted K/L struc-
tures with four- and seven-stranded parallel L-sheets, respec-
tively.
Some PTS proteins play a role in intracellular signal trans-
duction in addition to their transport function. These subunits
regulate their targets either allosterically or by phosphoryla-
tion. Their regulatory activity varies with the degree of phos-
phorylation (ratio of non-phosphorylated to phosphorylated
form) which in turn varies with the ratio of sugar-dependent
dephosphorylation and PEP-dependent rephosphorylation
[11]. Examples of regulatory functions exerted by the glu-
cose-speci¢c PTS of E. coli are summarized in Fig. 4. Dephos-
phorylated EI inhibits the sensor kinase CheA of the bacterial
chemotaxis machinery [12]. The dephosphorylated IIAGlc sub-
unit inhibits glycerolkinase (GK) [13], phosphorylated IIAGlc
activates adenylate cyclase (Cya) [14]. Dephosphorylated
IICBGlc binds and thereby sequesters the transcriptional re-
pressor protein Mlc. Free Mlc blocks the expression of genes
involved in glucose transport and metabolism, and these genes
become derepressed whenever glucose is transported and
IICBGlc thereby is dephosphorylated [15^18,66,67]. Another
regulatory mechanism (not shown) is the (in)activation of
transcription factors (repressors and anti-terminators) by
PTS protein-mediated phosphorylation (for a review see [19]).
The discovery of new PTS-related sequences in the bacterial
genomes continues, and suggests, that PTSs might have addi-
tional and as yet unknown functions. For instance, the dihy-
droxyacetone kinase of E. coli utilizes a PTS protein instead
of ATP as phosphoryl donor (Fig. 2, [20,21]). EINtr, an EI-like
protein consisting of a N-terminal NifA and a C-terminal EI-
like domain [22] is a virulence factor in the Pseudomonas aeru-
ginosa PA14- Caenorhabditis elegans slow killing model [23].
EINtr mutants are less pathogenic not only in C. elegans but
also in the plant Arabidopsis thaliana and in mice. In addition
to EINtr there are other PTS proteins which more tentatively
have been associated with bacterial virulence [24^27].
2. The IICBGlc subunit of the glucose transporter
2.1. Structure and function of IICBGlc
The IICBGlc subunit (50.7 kDa) consists of two domains,
Fig. 3. Diversity of folds. Cartoons of IIA and IIB domains/sub-
units of di¡erent PTS transporters. Phosphorylatable residues are
represented as green sticks, other active site residues in red and
blue. IIALac is a trimer, IIAMan a dimer, the other domains are
monomeric. The PDB access codes and references: IIAGlc (1F3G,
[57]); IIAMtl (1A3A, [58]); IIAMan (1PDO, [59]); IIALac (1E2A,
[60]); IIBGlc (1IBA, [61]); IIBCel (1IIB, [62]) IIBLev (1BLE, [63]).
Fig. 4. Energy- and signal transduction by the glucose PTS. Regula-
tory events occurring in the presence of Glc are emphasized in
green, those occurring in its absence in red. In the presence of Glc,
a large fraction of IIAGlc and IICBGlc is dephosphorylated in the
steady state. IICBGlc binds the Mlc repressor, and genes encoding
PTS proteins (general and Glc-speci¢c) can be transcribed by RNA
polymerase (black ovals). IIAGlc binds and inhibits the lactose trans-
porter (LacY) and prevents uptake of lactose (inducer exclusion).
IIAGlc also binds and inhibits other targets, e.g. GK. The (more) ac-
tive forms of these targets are labelled with two stars. In the ab-
sence of Glc, IIAGlc and IICBGlc mostly are in the phosphorylated
form. Mlc is not sequestered by P-IICBGlc. Mlc binds to operator
DNA and represses the transcription of glucose-speci¢c and other
genes. P-IIAGlc does not bind to GK and other targets of IIAGlc,
but instead activates Cya. cAMP binds to the catabolite repressor
protein (CRP) which when complexed with cAMP activates the
transcription of (catabolite repressed) genes. Activation occurs only
under the condition that a speci¢c inducer, e.g. lactose is present.
CheA, the sensor kinase of the bacterial chemotaxis system is inhib-
ited by dephosphorylated EI. Sources and sinks of phosphate are
shown in blue. EI-kinase (EI-KNADH) and acetate kinase (AckA)
can feed phosphate from ATP into the phosphotransfer chain
[64,65]. IIASug are IIA subunits of other transporters (Fig. 2) which
can compete with IIAGlc for P-HPr. Work summarized in this ¢gure
is from the laboratories of S. Roseman, J. Plumbridge, H. Aiba,
P. Postma, M. Saier and J. Lengeler (for references see text).
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the membrane bound C (41.1 kDa) and the cytoplasmic B
domain (9.6 kDa). There exist over 30 sequences of ortholo-
gous and paralogous proteins with a⁄nity for Glc or GlcNAc.
Overall sequence similarities are stronger in the second half of
the sequence from cytoplasmic loop 2 to the end (Fig. 5A).
The C domain contains the sugar binding site, as concluded
from the speci¢city of a IICBGlc/IICBAGlcNAc chimera [28],
and point mutations conferring relaxed substrate speci¢city
[16,18,29^32]. It comprises eight putative membrane spanning
segments (Fig. 5), a topology which was ¢rst derived from the
activity of fusion proteins between IICBGlc and L-galactosi-
dase or alkaline phosphatase [33] and further con¢rmed by
random linker insertion mutagenesis [34]. Mutants which re-
tained between 50 and 100% activity carried inserts and dele-
tions in the putatively periplasmic loops I, II and III, at the
end of the cytoplasmic domain (loop III) and in the linker
between the IIC and IIB domain. A projection map of 2D
crystals [35] indicates a dimeric structure of IICGlc, in agree-
ment with results of inter-allelic complementation (Fig. 6B),
crosslinking and copuri¢cation of heterodimers [36^39].
The IIB domain consists of a four-stranded antiparallel L-
sheet and three helices packed against one side of the sheet
(Fig. 3). The phosphorylatable Cys421 is highly exposed in the
loop between strands L1 and L2 which leads to artifactual
disul¢de crosslinking of subunits in the puri¢ed dimer [37].
Next to Cys421 on the surface of the L-sheet and also invar-
iant in the transporters of the glucose family are Arg424 and
Arg426. The two arginines are essential for Glc phosphoryla-
tion and transport, but not for the phosphorylation of
IICBGlc by IIAGlc [39]. Only the C421S substitution also abol-
ishes phosphorylation of IICBGlc by IIAGlc (Fig. 6A,B, [40]).
IIC and IIB are £exibly linked and complementation be-
tween domains of di¡erent inactive subunits is possible (Fig.
6B, [39]). At present we do not know, whether complementa-
tion occurs between colliding homodimers, or in heterodimers
formed by subunit exchange. The interdomain region is sus-
ceptible to proteolysis around the position indicated with the
red arrow in Fig. 5. Phosphorylation of IICBGlc partially pro-
tects against chymotryptic cleavage indicating that the inter-
domain region undergoes a conformational change upon
phosphorylation (Fig. 6C). This region comprises a short mo-
tif (LKTPGRED, Fig. 5) which is strongly conserved in all
transporters of the glucose family. Surprisingly, most modi¢-
Fig. 5. Topology of the IICBGlc subunit. A: Activity of fusion pro-
teins between IICBGlc and alkaline phosphatase (blue) or L-galacto-
sidase (red). Activities are plotted against the residue at fusion
point. Similarity plot of subunits from the glucose family of PTS
transporters (green). Important residues at sites of maximum simi-
larity are indicated. The average similarity of the entire sequence
was 1.1. B: Transmembrane topology of IICBGlc. Residues fused to
alkaline phosphatase and L-galactosidase are blue and red. Red tri-
angles and numbers indicate positions tolerant to insertion/deletions
of the indicated length. The green arrow indicates the position at
which IICBGlc was split and circularly permuted. The red arrow in-
dicates the chymotryptic cleavage site. The IIB domain, and the in-
variant motif of the linker region are framed.
Fig. 6. Functional properties of IICBGlc mutants. (A) Puri¢ed
IICBGlc mutants indicated at the top were incubated with [32P]PEP
and the puri¢ed PTS proteins indicated on the left in the absence
(3) and presence (+) of Glc in excess over PEP. Mutants which are
phosphorylated by IIAGlc, but cannot transfer the phosphoryl group
to Glc are labelled. Wild-type and mutants which are active become
completely dephosphorylated in the presence of Glc. Shown is the
autoradiogram of an polyacrylamide gel. B: Inter-allelic complemen-
tation of Glc phosphotransferase activity between puri¢ed H212Q/
R424K (7), H212Q/R426K (E) and R424K/R426K (7). The activity
maximum corresponds to 10% of wild-type-speci¢c activity. It is not
clear whether complementation occurs between subunits in hetero-
dimers or between homodimers of IICBGlc. C: P-IICBGlc is stabi-
lized against chymotryptic cleavage of the interdomain linker region.
Puri¢ed IICBGlc was incubated for 10 min with (+) and without (3)
PEP in the presence of catalytic concentrations of EI, HPr and
IIAGlc. 0.5 mg/ml IICBGlc were digested with the indicated concen-
trations of chymotrypsin for 30 min. Shown is a Coomassie blue-
stained gel of the proteolytic products. D: Alanine-scanning muta-
genesis of the invariant motif in the interdomain linker region. Spe-
ci¢c Glc phosphotransferase activity of the puri¢ed proteins in per-
cent of wild-type.
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cations at this motif do not compromise transport and phos-
phorylation activity. The IICBGlc subunit can be split within
this motif, and the combined puri¢ed domains have in vitro
glucose phosphotransferase activity [41]. The motif also is the
only crossover point for functional chimeric proteins between
IICBGlc and IICBAGlcNAc, whereas the chimeras with fusion
joints at Ser45, Ala68, Pro154 have spurious activity only ([28]
and unpublished observations). Alanine mutations in the mo-
tif either have no e¡ect or reduce PTS activity to between 10%
and 60% (Fig. 6D, [39]). Only the G385A substitution and a
deletion of the motif reduce phosphorylation and uptake ac-
tivity to below 1% of wild-type. What function then does this
motif have? One hypothesis suggests, that it is (part of) the
binding site for the Mlc repressor (Fig. 3) in response to the
phosphorylation state of IICBGlc [18,42].
2.2. Mutants of IICBGlc
Substrate speci¢city mutants catalyze phosphorylation and
uptake of additional sugars (e.g. GlcNAc and Man) [16,18,29]
or permit facilitated di¡usion of substrates (ribose, fructose,
mannitol) without concomitant phosphorylation [30^32]. The
substrate speci¢cities are only relaxed and uncoupling between
translocation and phosphorylation is conditional. This means
that the mutants retain nearly normal phosphorylation and
transport activity towards Glc. KM for the non-cognate sub-
strates is high and the Vmax low. Another group of mutants
has reduced transport activity (less than 5%) for Glc but al-
most normal phosphorylation activity (20^70%). Uptake of K-
methylglucoside is 4^10U more strongly inhibited than up-
take of Glc, most likely because these mutants were selected
against uptake of the toxic analog K-methylglucoside and for
phosphorylation of intracellular glucose [43]. The H112Q mu-
tation blocks transport but not phosphorylation. In H111Q
both activities are moderately reduced. The mutants described
above are distributed all over the IIC domain, and an obvious
correlation between structure and function has yet to emerge.
3. Split, circularly permuted and cyclic forms of IICBGlc
With the objective to stabilize the interaction between the
IIC and IIB domains, circularly permuted [44] and cyclized
variants of IICBGlc (C. Siebold, unpublished results) were
constructed. In an attempt to break the membrane spanning
IIC domain into smaller parts, variants split in the IIC do-
main were also characterized [34].
3.1. Split variants
The IIC domain was split at the sites which had previously
been shown to tolerate amino acid insertions and deletions
(Fig. 5B, Section 2.1). A discontinuity of the polypeptide at
these sites reduced the phosphotransferase activity to between
7% and 32%. The variant split in the C-terminal end of the
cytoplasmic domain (loop III) had the highest activity and
was puri¢ed. The two polypeptides copuri¢ed and could not
be separated without denaturation of the complex. The split
variant is 30U more active when the proteins are encoded by
a bicistronic operon than by genes on two compatible plas-
mids [34]. This indicates that spatial proximity during protein
synthesis might favor assembly and membrane insertion of the
two fragments. It is not known whether the two halves inde-
pendently insert into the membrane and then assemble, or
whether they associate ¢rst and then insert as a complex.
3.2. Circularly permuted variants
Native N- and C-termini of IICBGlc were joined by an Ala^
Pro rich linker and new N- and C-termini were introduced in
all seven periplasmic and cytoplasmic loops (Fig. 7). Variants
Fig. 8. Cyclized proteins. A: Model of the IIAGlc and IICBGlc sub-
units of the glucose transporter. The active site Cys421 of IICBGlc
(1IBA) and the active site His90 of IIAGlc (PDB code 2F3G) are
shown in stick representation. The sites of cyclization are shown as
broken lines between the native N- and C-termini. (B, C) Lineariza-
tion of cyclized IIAGlc and IICBGlc with chymotrypsin. Note the de-
crease of electrophoretic mobility upon linearization of the cyclic
forms. Lanes 1: puri¢ed wild-type IIAGlc and IICBGlc (references).
Lanes 2: No chymotrypsin. Lanes 3^8: with increasing concentra-
tions of chymotrypsin (2 to 500 Wg/ml in B; 2 ng/ml to 167 Wg/ml
in C. D, E: Glucose phosphotransferase activity puri¢ed cyclized
IIAGlc (D) and IICBGlc (E). Cyclized forms (squares), wild-type
forms (circles). Shown are means þ S.D. of two independent assays.
Fig. 7. Topology and activity of the circularly permuted variants of
IICBGlc. The + symbol indicates the amount of protein detected
with an anti-IICBGlc antibody on Western blots. The numbers indi-
cate in percent of wild-type: transport activity of intact cells ex-
pressing the permuted IICBGlc/speci¢c Glc phosphotransferase activ-
ity of membrane fractions. The values are relative to total protein
and are not corrected for the di¡erent expression level of IICBGlc.
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with the termini in the periplasmic loops I and II had between
30% and 50% activity. The variants with termini in putative
periplasmic loops III and IV were not stable. Of the variants
with termini on the cytoplasmic side, only the one modi¢ed in
loop III was active. Fusion of alkaline phosphatase to the
C-termini in the periplasm stabilized membrane integration
and increased activity, in particular of the variant with the
N-terminus in periplasmic loop I (Fig. 7 bottom row). These
results further con¢rm that internal signal anchor and stop
transfer sequences can function as N-terminal signal sequen-
ces, and that the orientation of transmembrane segments is
determined by the amino acid sequence and not by their se-
quential appearance during translation [45,46]. It appears that
alkaline phosphatase helps to anchor the protein in the mem-
brane possibly by preventing the last segment from slipping
back. In the circularly permuted fusion protein the IIC do-
main is now sandwiched between two soluble domains, an
‘immobilized’ B-domain on the cytoplasmic and alkaline
phosphatase on the periplasmic side. Whether they help pro-
tein crystallization as did the Fv fragments, remains to be
demonstrated.
3.3. Cyclic IICBGlc and IIAGlc
The N- and C-termini of proteins are often close together
and have their surface exposed [47] and, therefore, can be
joined together to a¡ord a cyclized protein. Such proteins
are expected to be resistant against N- and C-peptidases and
to be more stable because of the lower entropy of their un-
folded states. Partial immobilization of unstructured ends by
crosslinking could facilitate protein crystallization. Cyclized
IICBGlc and IIAGlc subunits were produced by in vivo splicing
and characterized (Fig. 8A; C. Siebold, unpublished results).
Protein splicing is a posttranslational process, by which an
internal sequence (intein) of a precursor protein is removed by
cleavage of two peptide bonds and the two £anking sequences
(N-extein and C-extein) are ligated through a native peptide
bond. The splice reaction involves four nucleophilic substitu-
tion reactions (N^S, S^S, N^N and S^N acyl shifts) and is
catalyzed by the intein (for reviews see [48,49]). The N- and
C-exteins are the substrates of this reaction but do not have
splicing activity of their own. Inteins can be used to prepare
cyclized proteins [50^52] because the central portion of the
intein is not necessary for function and the £anking regions
do not need to be linked covalently for splicing activity. A
circularly permuted linear precursor comprising in this order
the C-terminal half of the recA intein of M. tuberculosis,
IICBGlc or IIAGlc to be cyclized and the N-terminal half of
the recA intein were produced in vivo using a recombinant
gene constructed according to previous methods [53^55]. A 20
residue long Ala^Pro rich linker peptide and a histidine tag
were used to join the native N- and C-termini (Fig. 9).
The cyclic forms of IIAGlc and IICBGlc complemented
growth of glucose auxotrophic strains. Precursor and pro-
cessed forms of IICBGlc were in the membrane fraction. The
cyclized form could be solubilized completely in n-dodecyl-
maltoside whereas the precursor was more or less insoluble
in the non-ionic detergent. The linear IIAGlc precursor was
strongly expressed but most of it was in inclusion bodies.
Cyclized IIAGlc, however, was soluble. The cyclic proteins
could be puri¢ed by metal chelate a⁄nity chromatography
with a yield of 10% compared to the wild-type proteins. Cyclic
IICBGlc had 30%, cyclic IIAGlc 100% of wild-type glucose
phosphotransferase activity (Fig. 8D,E). Both proteins had
an increased electrophoretic mobility which decreased upon
linearization of the proteins with chymotrypsin (Fig. 8B,C).
The stabilities of cyclized and linear IIAGlc were compared by
temperature and GuHCl-induced unfolding (Fig. 10). The
transition midpoint for GuHCl-induced unfolding was shifted
Fig. 9. Plasmid map and structure of the circularly permuted intein-
IICBGlc (purple-orange) precursor. A: Plasmid map. The nucleotide
and amino acid sequences of the splice sites are indicated. The two
cysteine at the Asn/Cys and Lys/Cys splice junction catalyze the
S^N acyl shift reactions. B: Structure of precursor proteins. The
IICBGlc precursor contains an Ala^Pro linker (striped) and a His-
tag (gray) at the splice junction. The IICBGlc variant with the active
site Cys421 at the N-terminal splice junction did not a¡ord a circu-
larized protein. The IIAGlc variant contained a His-tag only. Resi-
due numbers refer to the IICBGlc wild-type sequence. (Swiss-Prot
accession number P05053; IIAGlc P08837).
Fig. 10. GuHCl- and temperature-induced unfolding of cyclized and
wild-type IIAGlc. A: Cyclized IIAGlc (red, closed circles); wild-type
IIAGlc (green, open squares). The smoothed curves show the mean
and the 95% con¢dence band (broken lines). B: Cyclized IIAGlc :
Unfolding transition (red, open circles), refolding transition (red,
closed circles). C: Wild-type IIAGlc : unfolding transition (green,
open squares), refolding transition (green, closed squares). To facili-
tate comparison, the smoothed curves drawn through the data
points of C are also plotted in B and vice versa in C (broken lines).
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from 1.1 M to 1.5 M for cyclized IIAGlc (Fig. 6A). The tran-
sition temperature of unfolding was 75‡C for cyclized IIAGlc
and 70‡C for linear IIAGlc (Fig. 10B,C). The midpoint temper-
atures of refolding were 71‡C and 66‡C respectively. Phospho-
transferase activity of cyclized and linear proteins was recov-
ered completely after cooling, indicating that both assumed
the catalytically active fold.
In conclusion, IIAGlc can be stabilized by cyclization. How-
ever the yield of cyclized protein is too low to start crystal-
lization experiments with it. The objective of future experi-
ments is to improve the e⁄ciency of cyclization. Results
reported for DnaE-mediated in vivo cyclization [51] suggest
that this naturally split intein may be more suitable because its
two halves have an intrinsically strong a⁄nity. Alternatively,
the association between the two RecA intein fragments might
be strengthened by fusion of leucine zippers to the N- and
C-termini of the precursor.
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